Clareo Health | Continued Access Study to Evaluate Performance of the Organ Recovery Systems _LifePort® Liver Transporter System, a Machine Perfusion System, for Liver Transplant (PILOT™_CA)
Continued Access Study to Evaluate Performance of the Organ Recovery Systems _LifePort® Liver Transporter System, a Machine Perfusion System, for Liver Transplant (PILOT™_CA)
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Organ Recovery Systems, Inc.
To provide continued access for the LLT System with Vasosol® for the preservation of whole explanted livers, thereby providing additional safety data in support of the PILOT pivotal efficacy and safety trial
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
≥18 years of age.
Active on the United Network for Organ Sharing (UNOS) waiting list for liver transplantation.
De novo liver transplant recipient.
Written informed consent required.
You may not be if
Subject is a multi-organ transplant recipient.
Subject is antibodies blood group (ABO) liver incompatible.
Subject has severe systemic infection.
Subject is Human Immunodeficiency Virus (HIV) positive.
